First Turn Management, LLC — 13F Holdings & Portfolio
CIK 1993440 · latest 13F-HR filed 2026-08-14
First Turn Management, LLC manages $934.7M in 13F-reported U.S. long-equity assets across 31 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are RVMD (8.32%), ABVX (6.98%), AXSM (5.72%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 6 new positions, exited 8, added to 14, and trimmed 11.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
DEL MAR, CA 92014
$934.7M
Long-equity book
31
Distinct positions
2026-06-30
Filed 2026-08-14
+6 / −8 / ↑14 / ↓11
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- REVOLUTION MEDICINES INC$32.2M +70.8%
- CYTOKINETICS INC$26.2M +140.3%
- ENLIVEN THERAPEUTICS INC$24.0M +98.1%
- AXSOME THERAPEUTICS INC.$21.6M +67.6%
- UNIQURE NV$18.0M +178.7%
Top Trims
- NUVALENT INC-$34.7M -91.4%
- APOGEE THERAPEUTICS INC-$24.8M -57.4%
- UNITED THERAPEUTICS CORP DEL-$16.1M -25.9%
- COGENT BIOSCIENCES INC-$13.2M -36.1%
- INSMED INC-$12.5M -30.8%
New Positions
- ASCENDIS PHARMA A/S$28.0M
- VAXCYTE INC$25.8M
- RHYTHM PHARMACEUTICALS INC$17.1M
- INHIBRX BIOSCIENCES INC$15.6M
- ORUKA THERAPEUTICS INC$14.8M
Exited Positions
- IDEAYA BIOSCIENCES INC$29.1M
- ASCENDIS PHARMA A/S$17.5M
- FULCRUM THERAPEUTICS INC$17.3M
- TERNS PHARMACEUTICALS INC$17.2M
- VERA THERAPEUTICS INC$17.0M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $77.8M | 8.32% | 415,307 | SH |
| 2 | ABIVAX SA | ABVX | 00370M103 | $65.3M | 6.98% | 489,889 | SH |
| 3 | AXSOME THERAPEUTICS INC. | AXSM | 05464T104 | $53.5M | 5.72% | 218,415 | SH |
| 4 | ENLIVEN THERAPEUTICS INC | ELVN | 29337E102 | $48.4M | 5.18% | 954,360 | SH |
| 5 | BRIDGEBIO PHARMA INC | BBIO | 10806X102 | $47.2M | 5.05% | 633,364 | SH |
| 6 | ROIVANT SCIENCES LTD | ROIV | G76279101 | $47.1M | 5.04% | 1,331,066 | SH |
| 7 | UNITED THERAPEUTICS CORP DEL | UTHR | 91307C102 | $46.0M | 4.92% | 84,932 | SH |
| 8 | CYTOKINETICS INC | CYTK | 23282W605 | $44.9M | 4.81% | 527,412 | SH |
| 9 | XENON PHARMACEUTICALS INC | XENE | 98420N105 | $36.2M | 3.88% | 600,200 | SH |
| 10 | CELCUITY INC | CELC | 15102K100 | $34.4M | 3.68% | 329,101 | SH |
| 11 | VIRIDIAN THERAPEUTICS INC | VRDN | 92790C104 | $30.7M | 3.28% | 1,670,000 | SH |
| 12 | INSMED INC | INSM | 457669307 | $28.1M | 3.01% | 263,851 | SH |
| 13 | UNIQURE NV | QURE | N90064101 | $28.0M | 3.00% | 608,925 | SH |
| 14 | ASCENDIS PHARMA A/S | ASND | K08588103 | $28.0M | 2.99% | 104,877 | SH |
| 15 | PRAXIS PRECISION MEDICINES I | PRAX | 74006W207 | $28.0M | 2.99% | 83,528 | SH |
| 16 | DIANTHUS THERAPEUTICS INC | DNTH | 252828108 | $27.9M | 2.98% | 285,771 | SH |
| 17 | VAXCYTE INC | PCVX | 92243G108 | $25.8M | 2.76% | 443,836 | SH |
| 18 | MIRUM PHARMACEUTICALS INC | MIRM | 604749101 | $25.5M | 2.73% | 218,051 | SH |
| 19 | PALVELLA THERAPEUTICS INC NE | PVLA | 697947109 | $23.9M | 2.56% | 156,450 | SH |
| 20 | COGENT BIOSCIENCES INC | COGT | 19240Q201 | $23.3M | 2.49% | 602,281 | SH |
| 21 | ERASCA INC | ERAS | 29479A108 | $22.4M | 2.39% | 1,221,721 | SH |
| 22 | ORIC PHARMACEUTICALS INC | ORIC | 68622P109 | $21.8M | 2.34% | 2,017,284 | SH |
| 23 | NEWAMSTERDAM PHARMA COMPANY | NAMS | N62509109 | $19.7M | 2.11% | 582,497 | SH |
| 24 | APOGEE THERAPEUTICS INC | APGE | 03770N101 | $18.4M | 1.97% | 138,822 | SH |
| 25 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $17.1M | 1.83% | 154,018 | SH |
| 26 | INHIBRX BIOSCIENCES INC | INBX | 45720N103 | $15.6M | 1.67% | 164,783 | SH |
| 27 | SCHOLAR ROCK HLDG CORP | SRRK | 80706P103 | $14.9M | 1.60% | 271,227 | SH |
| 28 | ORUKA THERAPEUTICS INC | ORKA | 687604108 | $14.8M | 1.58% | 155,343 | SH |
| 29 | KYMERA THERAPEUTICS INC | KYMR | 501575104 | $11.8M | 1.26% | 102,533 | SH |
| 30 | SIONNA THERAPEUTICS INC | SION | 829401108 | $4.9M | 0.52% | 110,493 | SH |
| 31 | NUVALENT INC | NUVL | 670703107 | $3.2M | 0.35% | 26,298 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $934.7M | 31 | 0001993440-26-000004 |
| 2026-03-31 | 2026-05-15 | $895.1M | 33 | 0001993440-26-000002 |
| 2025-12-31 | 2026-02-13 | $875.2M | 33 | 0001993440-26-000001 |
| 2025-09-30 | 2025-11-14 | $666.0M | 29 | 0001993440-25-000004 |